FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2982482012> ?p ?o ?g. }

• W2982482012 endingPage "670" @default.
• W2982482012 startingPage "661" @default.
• W2982482012 abstract "Abstract Introduction Alzheimer's disease (AD) is a continuum with neuropathologies manifesting years before clinical symptoms; thus, AD research is attempting to identify more disease‐modifying approaches to test treatments administered before full disease expression. Designing such trials in cognitively normal elderly individuals poses unique challenges. Methods The TOMMORROW study was a phase 3 double‐blind, parallel‐group study designed to support qualification of a novel genetic biomarker risk assignment algorithm (BRAA) and to assess efficacy and safety of low‐dose pioglitazone to delay onset of mild cognitive impairment due to AD. Eligible participants were stratified based on the BRAA (using TOMM40 rs 10524523 genotype, Apolipoprotein E genotype, and age), with high‐risk individuals receiving low‐dose pioglitazone or placebo and low‐risk individuals receiving placebo. The primary endpoint was time to the event of mild cognitive impairment due to AD. The primary objectives were to compare the primary endpoint between high‐ and low‐risk placebo groups (for BRAA qualification) and between high‐risk pioglitazone and high‐risk placebo groups (for pioglitazone efficacy). Approximately 300 individuals were also asked to participate in a volumetric magnetic resonance imaging substudy at selected sites. Results The focus of this paper is on the design of the study; study results will be presented in a separate paper. Discussion The design of the TOMMORROW study addressed many key challenges to conducting a dual‐objective phase 3 pivotal AD clinical trial in presymptomatic individuals. Experiences from planning and executing the TOMMORROW study may benefit future AD prevention/delay‐of‐onset trials." @default.
• W2982482012 created "2019-11-08" @default.
• W2982482012 creator A5002154844 @default.
• W2982482012 creator A5002233555 @default.
• W2982482012 creator A5002457905 @default.
• W2982482012 creator A5012583502 @default.
• W2982482012 creator A5014182690 @default.
• W2982482012 creator A5017030625 @default.
• W2982482012 creator A5019090648 @default.
• W2982482012 creator A5039685465 @default.
• W2982482012 creator A5041462351 @default.
• W2982482012 creator A5059809072 @default.
• W2982482012 creator A5062699404 @default.
• W2982482012 creator A5063838204 @default.
• W2982482012 creator A5067445016 @default.
• W2982482012 creator A5067472234 @default.
• W2982482012 creator A5082080191 @default.
• W2982482012 creator A5082869062 @default.
• W2982482012 creator A5085973698 @default.
• W2982482012 creator A5088514884 @default.
• W2982482012 date "2019-01-01" @default.
• W2982482012 modified "2023-10-15" @default.
• W2982482012 title "The TOMMORROW study: Design of an Alzheimer's disease delay‐of‐onset clinical trial" @default.
• W2982482012 cites W1486207314 @default.
• W2982482012 cites W1578837987 @default.
• W2982482012 cites W1622703765 @default.
• W2982482012 cites W1985579937 @default.
• W2982482012 cites W1988840297 @default.
• W2982482012 cites W1994397669 @default.
• W2982482012 cites W2007047564 @default.
• W2982482012 cites W2018647543 @default.
• W2982482012 cites W2028883654 @default.
• W2982482012 cites W2033105784 @default.
• W2982482012 cites W2037169299 @default.
• W2982482012 cites W2049190733 @default.
• W2982482012 cites W2055727638 @default.
• W2982482012 cites W2058799638 @default.
• W2982482012 cites W2061602279 @default.
• W2982482012 cites W2076268319 @default.
• W2982482012 cites W2079183773 @default.
• W2982482012 cites W2086572083 @default.
• W2982482012 cites W2088357373 @default.
• W2982482012 cites W2090161678 @default.
• W2982482012 cites W2092814867 @default.
• W2982482012 cites W2115017507 @default.
• W2982482012 cites W2119197968 @default.
• W2982482012 cites W2126677724 @default.
• W2982482012 cites W2129497119 @default.
• W2982482012 cites W2131266318 @default.
• W2982482012 cites W2138672217 @default.
• W2982482012 cites W2141282621 @default.
• W2982482012 cites W2142922534 @default.
• W2982482012 cites W2146876810 @default.
• W2982482012 cites W2147048440 @default.
• W2982482012 cites W2151380928 @default.
• W2982482012 cites W2152715003 @default.
• W2982482012 cites W2166853536 @default.
• W2982482012 cites W2223865021 @default.
• W2982482012 cites W2258850935 @default.
• W2982482012 cites W2551232524 @default.
• W2982482012 cites W2582524520 @default.
• W2982482012 cites W2727037715 @default.
• W2982482012 cites W2750686292 @default.
• W2982482012 cites W2883706737 @default.
• W2982482012 cites W2889787710 @default.
• W2982482012 cites W2899764361 @default.
• W2982482012 cites W2914934084 @default.
• W2982482012 cites W2918066696 @default.
• W2982482012 cites W2953975620 @default.
• W2982482012 doi "https://doi.org/10.1016/j.trci.2019.09.010" @default.
• W2982482012 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6838537" @default.
• W2982482012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31720367" @default.
• W2982482012 hasPublicationYear "2019" @default.
• W2982482012 type Work @default.
• W2982482012 sameAs 2982482012 @default.
• W2982482012 citedByCount "24" @default.
• W2982482012 countsByYear W29824820122020 @default.
• W2982482012 countsByYear W29824820122021 @default.
• W2982482012 countsByYear W29824820122022 @default.
• W2982482012 countsByYear W29824820122023 @default.
• W2982482012 crossrefType "journal-article" @default.
• W2982482012 hasAuthorship W2982482012A5002154844 @default.
• W2982482012 hasAuthorship W2982482012A5002233555 @default.
• W2982482012 hasAuthorship W2982482012A5002457905 @default.
• W2982482012 hasAuthorship W2982482012A5012583502 @default.
• W2982482012 hasAuthorship W2982482012A5014182690 @default.
• W2982482012 hasAuthorship W2982482012A5017030625 @default.
• W2982482012 hasAuthorship W2982482012A5019090648 @default.
• W2982482012 hasAuthorship W2982482012A5039685465 @default.
• W2982482012 hasAuthorship W2982482012A5041462351 @default.
• W2982482012 hasAuthorship W2982482012A5059809072 @default.
• W2982482012 hasAuthorship W2982482012A5062699404 @default.
• W2982482012 hasAuthorship W2982482012A5063838204 @default.
• W2982482012 hasAuthorship W2982482012A5067445016 @default.
• W2982482012 hasAuthorship W2982482012A5067472234 @default.
• W2982482012 hasAuthorship W2982482012A5082080191 @default.
• W2982482012 hasAuthorship W2982482012A5082869062 @default.
• W2982482012 hasAuthorship W2982482012A5085973698 @default.

• next